deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT01289301

Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant (BKVIRUS)

Polyomavirus BK Nephropathy After Renal Transplantation: Randomized Clinical Trial to Demonstrate That Switching to mTOR Inhibitor is More Effective Than a Reduction of Immunosuppressive Therapy

Sponsor: Hannover Medical School

Updated 6 times since 2017 Last updated: Feb 2, 2011 Started: Oct 31, 2011 Primary completion: Oct 31, 2017 Completion: Oct 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Disorder Related to Renal Transplantation and Immunosuppression Related Infectious Disease and is currently ongoing. Hannover Medical School leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Nov 2018 · 22 months · monthly snapshotNot Yet Recruiting~Nov 2018 – ~Jan 2021 · 26 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown StatusUnknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  5. Nov 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

    Status: Not Yet RecruitingUnknown Status

Show 1 earlier version
  1. Jan 2017 — Nov 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hannover Medical School
Data source: Hannover Medical School

For direct contact, visit the study record on ClinicalTrials.gov .